Related Experiment Video
Updated: Mar 10, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Neuropathic and Myopathic Pain
Anthony C Rodrigues1, Peter B Kang2
1Department of Pediatrics, Floating Hospital for Children at Tufts Medical Center, Boston, MA.
Insights
Understanding and treating childhood neuromuscular pain is improving with advances in genetics and neuroimmunology. New diagnostic tools and therapies will soon offer better relief for these complex conditions.
Area of Science:
- Pediatric Neurology
- Pain Management
- Neuromuscular Disorders
Background:
- Childhood pain syndromes of neuromuscular origin present unique challenges in diagnosis and management compared to adults.
- Pediatric patients' symptom description and disease presentation patterns differ, complicating assessment.
- Recent scientific and clinical advancements are improving care for children with these conditions.
Purpose of the Study:
- To highlight progress in the evaluation and management of childhood pain syndromes of neuromuscular origin.
- To discuss advancements in understanding genetic and neuroimmunological aspects of these diseases.
- To outline emerging diagnostic and therapeutic strategies for affected children.
Main Methods:
- Review of recent scientific and clinical knowledge in pediatric neuromuscular pain.
- Focus on genetic discoveries (e.g., Fabry disease, erythromelalgia) and neuroimmunological approaches.
- Examination of standardized treatment protocols (e.g., complex regional pain syndrome) and ongoing research into metabolic muscle diseases.
Main Results:
- Improved understanding of genetic origins for conditions like Fabry disease and inherited erythromelalgia.
- Development of more sophisticated diagnostic and therapeutic approaches driven by neuroimmunology.
- Standardization of treatment protocols for complex regional pain syndrome.
- Ongoing investigations into novel interventions for metabolic muscle diseases like McArdle disease and carnitine palmitoyl transferase deficiency type II.
Conclusions:
- Significant progress is being made in the care of children with neuromuscular pain syndromes.
- Future years promise more precise diagnostic tools and novel therapies for these distressing conditions.
- Advancements in genetics, neuroimmunology, and treatment protocols are enhancing pediatric pain management.
Abstract:
The evaluation and management of childhood pain syndromes of neuromuscular origin have distinct challenges, as the patterns of disease presentation and the ability of a child to describe symptoms may differ from that of an adult. Advances in scientific and clinical knowledge are leading to significant progress in the care of affected children. The genetic origins of Fabry disease and the inherited form of erythromelalgia are better understood. The increasing interest in neuroimmunology among pediatric neurologists has led to more sophisticated diagnostic and therapeutic approaches. Treatment protocols for complex regional pain syndrome have become more standardized. In addition, investigations continue into potential new interventions for metabolic muscle diseases such as McArdle disease and carnitine palmitoyl transferase deficiency type II. In the years to come, children with pain of neuromuscular origin will have access to more precise diagnostic tools and novel therapies that would alleviate this particularly distressing category of disease.
Related Concept Videos
Analgesia and Pain Management
Nociception
Pain
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Opioid Receptors: Overview
Neuromuscular Junction And Blockade

